Jim Simons Equillium, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Equillium, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 300,400 shares of EQ stock, worth $267,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300,400
Previous 209,200
43.59%
Holding current value
$267,356
Previous $483,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EQ
# of Institutions
28Shares Held
11.5MCall Options Held
38.1KPut Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$3.96 Million0.94% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$3.96 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$749,3330.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$500,4271.37% of portfolio
-
Geode Capital Management, LLC Boston, MA216KShares$192,4210.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $30.6M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...